Cellular and humoral immune responses to COVID-19 booster vaccination in Japanese dialysis patients.

Ayumi YoshifujiMasataro TodaEmi OyamaTetsuo NakayamaSetsuko Mise-OmataKan KikuchiMamoru YoshizawaNaohiko KatoHaruki WakaiKiyoto KoibuchiKohkichi MorimotoYoshifumi UwaminoHo NamkoongAyako ShibataKaoru WakabayashiMotoko FujinoMotoaki KomatsuNaoki MochizukiNorihiko KondoAkihiko YoshimuraNaoki HasegawaMunekazu Ryuzaki

Published in: Clinical and experimental nephrology (2024)

HD patients had significantly stronger cellular and humoral immune responses than the control 3 weeks after the booster dose. Our findings will help in developing better COVID-19 vaccination strategies for HD and PD patients.

Keyphrases

end stage renal disease
immune response
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
coronavirus disease
sars cov
prognostic factors
dendritic cells